With the global technical textiles market heading toward $200B by 2030 , KBLB’s timing could enable early adoption and prototype work for 2026 procurement cycles, especially in high-performance and ...

Scribe Therapeutics Inc. ("Scribe"), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...

Initiated registrational Phase 2b SAFEGUARD trial of SAB-142 in new-onset, Stage 3 autoimmune T1D patientsMultiple SAFEGUARD trial sites ...

Korro Bio saw its stock reach all-time lows on disappointing data for its lead pipeline candidate, while Intellia Therapeutics saw analyst downgrades on safety concerns despite releasing positive data ...

Standardized Recipe Development and Implementation The backbone of any successful restaurant's flavor consistency lies in ...

Advances being used to treat cancer are now being applied to lupus, rheumatoid arthritis, and other disorders.

Q3 2025 Earnings Call Transcript November 12, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is ...

Wildlife crossings over and under highways save lives, are cost effective and enhance the vitality and ecological functioning ...

Local residents were among 24 members of The University of Scranton’s class of 2025 who graduated from its Special Jesuit Liberal Arts Honors Program (SJLA). Students in SJLA pursue a rigorous ...

To maintain a perpetually “refreshed” look, cosmetic treatments are being sought earlier and more often. But what does it ...